✦ LIBER ✦

2016 LONG-TERM OUTCOMES FOLLOWING COMBINATION TREATMENT WITH BOCEPREVIR PLUS PEG-INTRON/RIBAVIRIN (P/R) IN PATIENTS WITH CHRONIC HEPATITIS C, GENOTYPE 1 (CHC-G1)

✍ Scribed by Vierling, J.M.; Ralston, R.; Lawitz, E.J.; McCone, J.; Gordon, S.; Pound, D.; Davis, M.; Galati, J.; Jacobson, I.; Rossaro, L.; Anderson, F.H.; King, J.; Cassidy, W.; Bourliere, M.; Esteban-Mur, R.; Ravendhran, N.; Galler, G.; Mendez, P.; Brass, C.A.; Albrecht, J.K.

Book ID: 122642807
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 134 KB
Volume: 52
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(10)61207-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Projecting the Long-Term Clinical Impact

Projecting the Long-Term Clinical Impact of Boceprevir in Patients With Chronic Hepatitis C Genotype-1 Who Failed Prior Treatment With Peginterferon/Ribavirin

✍ Chhatwal, Jagpreet ;Ferrante, Shannon A. ;Dasbach, Erik J. ;El Khoury, Antoine ; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 469 KB

1041 EFFICACY AND SAFETY OF ALBINTERFERO

1041 EFFICACY AND SAFETY OF ALBINTERFERON ALFA-2B IN COMBINATION WITH RIBAVIRIN IN TREATMENT- NAIVE, CHRONIC HEPATITIS C GENOTYPE 1 (CHC G1) PATIENTS

✍ Zeuzem, S.; Sulkowski, M.; Lawitz, E.; Rustgi, V.; Lurie, Y.; Grigorescu, M.; Mu 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

409 PROJECTING THE LONG-TERM CLINICAL IM

409 PROJECTING THE LONG-TERM CLINICAL IMPACT OF BOCEPREVIR IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE-1 WHO FAILED PRIOR TREATMENT WITH PEGINTERFERON/RIBAVIRIN

✍ J. Chhatwal; S.A. Ferrante; E.J. Dasbach; A. El Khoury; M. Burroughs; B. Bacon; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB

625 Efficacy of 6 months treatment with

625 Efficacy of 6 months treatment with peg-interferon α-2b plus ribavirin (P/R) in patients infected with hepatitis C with genotype 1 of low viral load (G1LVL)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Sa1050 Efficacy of Boceprevir Based Trip

Sa1050 Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Sa1041 Triple Therapy Under Real Life Co

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

✍ Moog, Gero; Mauss, Stefan; Hueppe, Dietrich; Spengler, Ulrich; Schott, Eckart; E 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 285 KB